Jan 25
Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant.
This is site is run by Sascha Endlicher, M.A., during ungodly late night hours. Wanna know more about him? Connect via Social Media by jumping to about.me/sascha.endlicher.
Post a Comment